EUCTR2008-007748-33-NL进行中(未招募)不适用
Dipeptide Alanyl Glutamine Prevents Postoperative Insulin Resistance in Colon Carcinoma Patients - AIRCo study
Foreest Medical School0 个研究点目标入组 20 人开始时间: 2008年12月11日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Colon cancer patients scheduled for elective abdominal surgery.
- •18 to 75 yrs.
- •Capable of giving informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Diabetes Mellitus
- •Thyroid medication
- •Anti-hypertensive medication
- •Corticosteroids
研究者
相似试验
招募中
不适用
Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma PatientsTemporary diabetes100184241001799110017998Insulin resistanceNL-OMON35623Medisch Centrum Alkmaar20
Unknown
不适用
Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma PatientsColon CarcinomaNCT00922688Medical Center Alkmaar30
已完成
不适用
Perioperative glutamine administration: a potential therapy for preventing post-operative immune hypo-responsivenessISRCTN86556841The Institute of Child Health (UK)96
招募中
3 期
Assessment of the ß-alanine effect in acute lower and upper extremity ischemiaIRCT20210919052515N5Oroumia University of Medical Sciences40
已完成
不适用
Intravenous glutamine-dipeptide and early nasojejunal feeding in severe acute pancreatitisDigestive SystemAcute pancreatitisSevere acute pancreatitisISRCTN60549685The Mulartz Henrik Surgical Foundation (Hungary)60
